argininosuccinate synthetase

ASS1 is a cytosolic enzyme expressed primarily in the liver that catalyzes the ATP-dependent condensation of citrulline and aspartate to form argininosuccinate, releasing AMP and pyrophosphate. This is the rate-limiting step of the urea cycle and the point at which nitrogen from aspartate (the second nitrogen atom of urea) enters the pathway. Argininosuccinate is subsequently cleaved by argininosuccinate lyase into arginine and fumarate; fumarate links the urea cycle to the TCA cycle, while arginine proceeds to be cleaved by arginase to form urea and ornithine, regenerating the cycle.

Deficiency of ASS1 causes citrullinemia type I (classic citrullinemia), an autosomal recessive disorder. Because the block occurs after citrulline formation but before argininosuccinate formation, citrulline accumulates in blood and urine along with elevated ammonia levels. Clinical presentation in the neonatal form includes hyperammonemia, lethargy, poor feeding, vomiting, seizures, and cerebral edema, often presenting in the first days of life after protein-containing feeds are introduced. Milder, later-onset forms exist with variable neurocognitive symptoms.

Diagnosis involves elevated plasma citrulline (markedly elevated, distinguishing it from other urea cycle disorders), elevated ammonia, and orotic aciduria (due to excess carbamoyl phosphate shunting into pyrimidine synthesis, similar to OTC deficiency but OTC deficiency is X-linked and has low citrulline). Treatment includes dietary protein restriction, arginine supplementation, nitrogen-scavenging drugs (sodium phenylbutyrate, sodium benzoate), and in severe cases, liver transplantation.

High-yield board points: distinguishing urea cycle enzyme deficiencies by their metabolite patterns (citrulline levels, orotic acid, ammonia) is a classic biochemistry question. ASS1 deficiency = high citrulline, high ammonia, orotic aciduria present (unlike CPS1 deficiency which has low citrulline and no orotic aciduria).